Plasma 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and growth hormone responses to yohimbine in panic disorder patients and normal controls
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 15 (3) , 217-224
- https://doi.org/10.1016/0306-4530(90)90032-5
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Growth hormone response to clonidine in anxiety disordersBiological Psychiatry, 1989
- Abnormal Regulation of Noradrenergic Function in Panic DisordersArchives of General Psychiatry, 1986
- Influence of yohimbine on release of anterior pituitary hormonesLife Sciences, 1986
- Noradrenergic Function in Panic AnxietyArchives of General Psychiatry, 1984
- URINARY EXCRETION OF NORADRENALINE METABOLITE DECREASED IN PANIC DISORDERThe Lancet, 1983
- Assessment of α2 adrenergic autoreceptor function in humans: Effects of oral yohimbineLife Sciences, 1982
- Further evidence for alpha-2 adrenergic receptor mediated inhibition of prolactin secretion: the effect of yohimbinePsychoneuroendocrinology, 1978
- Adrenergic receptor control mechanism for growth hormone secretionJournal of Clinical Investigation, 1968
- Yohimbine as an Autonomic Test DrugNature, 1962
- Autonomic and psychic effects of yohimbine hydrochloridePsychopharmacology, 1961